Form 4: Arcellx CEO Rami Elghandour Receives Shares Following Performance Criteria Achievement
SEC Form 4
Arcellx CEO Rami Elghandour acquired shares of common stock on February 27, 2025, following the achievement of performance criteria related to restricted stock awards.
Summary
- On February 27, 2025, Rami Elghandour, CEO of Arcellx, acquired 668,416 shares of common stock related to a performance-based restricted stock award granted on June 9, 2021, and amended on December 7, 2021.
- He also acquired 347,255 shares of common stock related to a performance-based restricted stock award granted on January 3, 2023.
- These shares vested upon partial achievement of performance criteria measured as of December 31, 2024, as determined by the Issuer's compensation committee.
- Following these transactions, Elghandour directly owns 1,164,857 shares of Arcellx common stock.
Sentiment
Score: 7
Explanation: The sentiment is moderately positive as the vesting of shares suggests that performance criteria were met, indicating progress for the company. However, the document is simply a regulatory filing and doesn't provide extensive details.
Positives
- The vesting of shares indicates that performance criteria were at least partially met, suggesting positive progress for Arcellx.
- The CEO's increased stake in the company aligns his interests with those of shareholders.
Industry Context
This type of equity award is common in the biotech industry to incentivize executives and align their interests with company performance.
Comparison to Industry Standards
- Performance-based equity awards are a standard practice in the biotechnology industry, often tied to clinical trial milestones, regulatory approvals, or commercialization targets.
- Companies like Gilead Sciences, Amgen, and Biogen also utilize similar compensation structures to incentivize their executives.
- The specific performance criteria for Arcellx's awards would need to be compared to those of its peers to assess the rigor and relevance of the targets.
Stakeholder Impact
- Shareholders may view the vesting of shares positively, as it suggests that the company is achieving its goals.
- Employees may be motivated by the fact that performance is being rewarded.
Key Dates
| Date | Description |
|---|---|
| June 9, 2021 | Date of original performance-based restricted stock award grant pursuant the Issuer's 2017 Equity Incentive Plan. |
| December 7, 2021 | Date of amendment to the performance-based restricted stock award granted on June 9, 2021. |
| January 3, 2023 | Date of performance-based restricted stock award grant pursuant the Issuer's 2022 Equity Incentive Plan. |
| December 31, 2024 | Measurement date for performance criteria related to the restricted stock awards. |
| February 27, 2025 | Date of stock acquisition by Rami Elghandour. |
Keywords
Arcellx, Rami Elghandour, stock, performance-based restricted stock award, CEO, shares, vesting, equity
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.